BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 36430804)

  • 1. Relevance of Complement C4 Deposits Localized to Distinct Vascular Compartments in ANCA-Associated Renal Vasculitis.
    Hakroush S; Kluge IA; Baier E; Tampe D; Tampe B
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-Reactive Protein Levels Are Associated with Complement C4 Deposits and Interstitial Arteritis in ANCA-Associated Renal Vasculitis.
    Korsten P; Baier E; Hakroush S; Tampe B
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrarenal synthesis of complement C3 localized to distinct vascular compartments in ANCA-associated renal vasculitis.
    Hakroush S; Tampe D; Baier E; Kluge IA; Ströbel P; Tampe B
    J Autoimmun; 2022 Dec; 133():102924. PubMed ID: 36209693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implication of platelets and complement C3 as link between innate immunity and tubulointerstitial injury in renal vasculitis with MPO-ANCA seropositivity.
    Baier E; Tampe D; Kluge IA; Hakroush S; Tampe B
    Front Immunol; 2022; 13():1054457. PubMed ID: 36439156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Histological Subtyping of Immune Cell Infiltrates in MPO-ANCA and PR3-ANCA Glomerulonephritis.
    Hakroush S; Tampe D; Ströbel P; Korsten P; Tampe B
    Front Immunol; 2021; 12():737708. PubMed ID: 34759920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement Components C3 and C4 Indicate Vasculitis Manifestations to Distinct Renal Compartments in ANCA-Associated Glomerulonephritis.
    Hakroush S; Tampe D; Korsten P; Ströbel P; Tampe B
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34205415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glomerular Immune Deposition in MPO-ANCA Associated Glomerulonephritis Is Associated With Poor Renal Survival.
    Lin W; Shen C; Zhong Y; Ooi JD; Eggenhuizen P; Zhou YO; Luo H; Huang J; Chen JB; Wu T; Meng T; Xiao Z; Ao X; Peng W; Tang R; Yin H; Xiao X; Zhou Q; Xiao P
    Front Immunol; 2021; 12():625672. PubMed ID: 33841408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics of patients with vasculitis positive for anti-neutrophil cytoplasmic antibody targeting both proteinase 3 and myeloperoxidase: a retrospective study.
    Kim SM; Choi SY; Kim SY; Kim J
    Rheumatol Int; 2019 Nov; 39(11):1919-1926. PubMed ID: 31552433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A population-based study showing better renal prognosis for proteinase 3 antineutrophil cytoplasmic antibody (ANCA)-associated nephritis versus myeloperoxidase ANCA-associated nephritis.
    Mohammad AJ; Segelmark M
    J Rheumatol; 2014 Jul; 41(7):1366-73. PubMed ID: 24882836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased renal damage in hypocomplementemic patients with ANCA-associated vasculitis: retrospective cohort study.
    García L; Pena CE; Maldonado RÁ; Costi C; Mamberti M; Martins E; García MA
    Clin Rheumatol; 2019 Oct; 38(10):2819-2824. PubMed ID: 31222573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histologic and immunohistologic study and clinical presentation of ANCA-associated glomerulonephritis with correlation to ANCA antigen specificity.
    Vizjak A; Rott T; Koselj-Kajtna M; Rozman B; Kaplan-Pavlovcic S; Ferluga D
    Am J Kidney Dis; 2003 Mar; 41(3):539-49. PubMed ID: 12612976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analysis of complement C3 and C4 serum levels for outcome prediction in ANCA-associated renal vasculitis.
    Tampe D; Baier E; Hakroush S; Tampe B
    J Nephrol; 2023 Jan; 36(1):125-132. PubMed ID: 35962865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measuring Circulating Complement Activation Products in Myeloperoxidase- and Proteinase 3-Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
    Wu EY; McInnis EA; Boyer-Suavet S; Mendoza CE; Aybar LT; Kennedy KB; Poulton CJ; Henderson CD; Hu Y; Hogan SL; Hu P; Xiao H; Nachman PH; Jennette JC; Falk RJ; Bunch DO
    Arthritis Rheumatol; 2019 Nov; 71(11):1894-1903. PubMed ID: 31215772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive Analysis of Sex Differences at Disease Manifestation in ANCA-Associated Glomerulonephritis.
    Tampe D; Korsten P; Ströbel P; Hakroush S; Tampe B
    Front Immunol; 2021; 12():736638. PubMed ID: 34630417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical and pathological characterization of antineutrophil cytoplasmic antibody associated small vasculitis in children].
    Zhou JH; Tang JH; Shi H; Liu TL; Qiu LR; Chen Y
    Zhonghua Er Ke Za Zhi; 2004 Jun; 42(6):408-11. PubMed ID: 15265421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement in ANCA-associated glomerulonephritis.
    Hilhorst M; van Paassen P; van Rie H; Bijnens N; Heerings-Rewinkel P; van Breda Vriesman P; Cohen Tervaert JW;
    Nephrol Dial Transplant; 2017 Aug; 32(8):1302-1313. PubMed ID: 26275893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement activation in pauci-immune necrotizing and crescentic glomerulonephritis: results of a proteomic analysis.
    Sethi S; Zand L; De Vriese AS; Specks U; Vrana JA; Kanwar S; Kurtin P; Theis JD; Angioi A; Cornell L; Fervenza FC
    Nephrol Dial Transplant; 2017 Jan; 32(suppl_1):i139-i145. PubMed ID: 28391334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of renal and patient outcomes in a Spanish cohort of patients with ANCA-associated vasculitis and renal involvement.
    Marco H; Draibe J; Villacorta J; Quintana LF; Martin N; Garcia-Osuna R; Cabre C; Martín-Gómez MA; Balius A; Saurina A; Picazo M; Gich-Saladich I; Navarro-Díaz M; Praga M; Cavero T; Ballarin J; Díaz-Encarnación MM;
    Clin Rheumatol; 2018 Apr; 37(4):1065-1074. PubMed ID: 29520673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between serologic profile (ANCA type) and clinical features of renal involvement in ANCA-associated vasculitides.
    Bulanov NM; Makarov EA; Shchegoleva EM; Zykova AS; Vinogradova ES; Novikov PI; Lysenko Kozlovskaya LV; Moiseev SV
    Ter Arkh; 2018 Jun; 90(6):15-21. PubMed ID: 30701899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical presentation and outcome prediction of clinical, serological, and histopathological classification schemes in ANCA-associated vasculitis with renal involvement.
    Córdova-Sánchez BM; Mejía-Vilet JM; Morales-Buenrostro LE; Loyola-Rodríguez G; Uribe-Uribe NO; Correa-Rotter R
    Clin Rheumatol; 2016 Jul; 35(7):1805-16. PubMed ID: 26852317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.